Novo Nordisk A/S (Novo Nordisk A/S) 5-Year Yield-on-Cost %

: 1.97 (As of Today)

View and export this data going back to 1981. Start your Free Trial

Novo Nordisk A/S's yield on cost for the quarter that ended in Dec. 2023 was 1.97.

The historical rank and industry rank for Novo Nordisk A/S's 5-Year Yield-on-Cost % or its related term are showing as below:

NVO' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.37 Med: 3.28 Max: 7.35
Current: 1.97

During the past 13 years, Novo Nordisk A/S's highest Yield on Cost was 7.35. The lowest was 1.37. And the median was 3.28.

NVO's 5-Year Yield-on-Cost % is ranked better than
50.34% of 149 companies
in the Biotechnology industry
Industry Median: 1.97 vs NVO: 1.97

Competitive Comparison

For the Biotechnology subindustry, Novo Nordisk A/S's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novo Nordisk A/S 5-Year Yield-on-Cost % Distribution

For the Biotechnology industry and Healthcare sector, Novo Nordisk A/S's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Novo Nordisk A/S's 5-Year Yield-on-Cost % falls into.

Novo Nordisk A/S 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Novo Nordisk A/S is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

Novo Nordisk A/S (NYSE:NVO) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Novo Nordisk A/S 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk A/S (Novo Nordisk A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (NYSE:NVO) » Definitions » 5-Year Yield-on-Cost %

Comparable Companies

Traded in Other Exchanges

NONOF:USA NOVOB:Mexico NVO:Mexico NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany N1VO34:Brazil NNO2:Austria

Address

Novo Alle 1, Bagsvaerd, DNK, DK-2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.